Cost-effectiveness of a modular intervention to support self-management in cardiovascular prevention: a health economic evaluation of the DECADE cluster-randomized trial
BACKGROUND: To evaluate the cost-effectiveness of two modular components of the DECADE intervention, structured patient-centered follow-up consultations ('Consultations') and patient materials for tailored use ('Materials'), for cardiovascular disease (CVD) prevention in German primary care. METHODS: The health economic evaluation was conducted alongside a 2 × 2 factorial cluster-randomized trial in German general practices. Patients aged 30-75 years with at least one lifestyle-related CVD risk factor were included. The cost-effectiveness of 'Consultations' was assessed by comparing groups that received structured follow-up consultations with those that did not. The cost-effectiveness of 'Materials' was assessed by comparing groups that received patient materials with those that did not. Incremental costs were combined with effects on the patient-reported Patient Activation Measure (PAM13) and the calculated 10-year cardiovascular risk (CVR) score. Incremental Cost-Effectiveness Ratios (ICERs) were calculated, and statistical uncertainty was assessed using non-parametric bootstrapping and cost-effectiveness acceptability curves. RESULTS: The 'Consultations' intervention showed a slight, significant improvement in the PAM13 score at 6 months of 1.14 points (95% CI 0.09 to 2.19, p = 0.033). The corresponding ICER was €89.48 (95% CI €46.42 to €1,105.30) per one-point PAM13 improvement. The 'Consultations' intervention did not affect the CVR score (p = 0.72). The 'Materials' intervention was associated with a noninformative result regarding the PAM13 score (p = 0.57), but was associated with a difference of - 1.63% points in the 10-year cardiovascular risk score relative to no materials, which was not statistically significant (95% CI - 3.28 to 0.02, p = 0.053). This difference reflects a stable risk score in the arms using materials (IG1 + 0.09, IG3 - 0.17) against a rising score in the arms without them (control group + 1.16, IG2 + 2.01) rather than an absolute reduction in risk. Based on an incremental cost of €15.03, the resulting ratio was €9.23 per percentage point of 10-year cardiovascular risk avoided (not statistically significant). CONCLUSIONS: Structured, patient-centered follow-up consultations slightly increased patient activation at moderate additional cost; as no willingness-to-pay threshold exists for this outcome, cost-effectiveness cannot be established. The low-cost patient materials did not improve patient activation; the calculated 10-year cardiovascular risk remained stable in the arms using them while it rose in the arms without them, but this difference is statistically uncertain. The modular design allows flexible implementation, and further evaluation with long-term and preference-based outcomes is needed.
Authors
- Henna Riemenschneider (ORCID: https://orcid.org/0000-0001-8348-487X)
- Andy Maun (ORCID: https://orcid.org/0000-0002-9213-6583)
- Melanie Kamp
- Susanne Kutter
- Anja Rakebrandt (ORCID: https://orcid.org/0000-0002-1599-0188)
- Iris Tinsel (ORCID: https://orcid.org/0000-0001-8689-9982)
- Maja Börger
- Thomas Kloppe (ORCID: https://orcid.org/0000-0002-2368-8333)
- Claudia Schmoor (ORCID: https://orcid.org/0000-0001-5610-9425)
- Hanna Hardt (ORCID: https://orcid.org/0009-0002-7523-2589)
- Klaus Kaier (ORCID: https://orcid.org/0000-0003-0837-6945)
- Willy Gräfe (ORCID: https://orcid.org/0009-0004-1094-933X)
Institutions
- University of Freiburg (DE)
- University Medical Center Freiburg (DE)
- University Medical Center Hamburg-Eppendorf (DE)
- Technische Universität Dresden (DE)
Publication Details
- Journal
- Cost Effectiveness and Resource Allocation
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1186/s12962-026-00863-5
- Primary Topic
- Health Systems, Economic Evaluations, Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Deutsche Forschungsgemeinschaft
- Albert-Ludwigs-Universität Freiburg
- Gemeinsame Bundesausschuss